openPR Logo
Press release

Radiopharmaceutical Market Future Trends And Industry Analysis To 2024

03-15-2017 04:14 PM CET | Health & Medicine

Press release from: Transparency Market Research – Pharmaceutical

Radiopharmaceutical Market Future Trends And Industry

Radiopharmaceutical Market: Scope and Trends

This report on the radiopharmaceutical market analyzes the current and future scenario of the global market. Increase in incidence of various diseases, development of new sources for radioisotope production, and rise in demand for nuclear medicine are boosting the radiopharmaceutical market. Increase in incidence of cancer and cardiovascular diseases, growth in awareness about effective use of radiopharmaceuticals, and rise in preference for SPECT and PET scans are some of the factors expected to drive the growth of the global radiopharmaceutical market during the forecast period.

Download Exclusive Brochure of This Report :

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=213

The radiopharmaceutical market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on radioisotopes, source, end-user, and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises Porters Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global radiopharmaceutical market.

Radiopharmaceutical Market: Segmentation

Based on radioisotope, the market has been segmented into Technetium-99, Lutetium-177, Rubidium-87, Iodine-123, Yttrium-90, and Gallium-62. Technetium-99 is the most widely used radioisotope across the globe; around 70% of radiopharmaceutical companies depend on Mo-99 to produce Technetium-99, as per the World Nuclear Association. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference for technological systems by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Based on source, the radiopharmaceutical market has been segmented into two major categories: nuclear reactors and cyclotrons. The market segments have been extensively analyzed based on increase in demand for radioisotopes for nuclear medicines, availability of radioisotopes and raw materials, radioisotopes short half-life and number of production units used for production of radioisotopes. Different types of end-user utilize radiopharmaceutical products to treat diseases either through imaging techniques or the therapeutics method.

Under the end-user segment, hospitals plays a major role followed by ambulatory surgical centers, diagnostic centers, and others (such as universities, research laboratories, and pathology labs). The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year. Application segment signifies the usage of radiopharmaceutical products through different disease indication such as oncology, cardiology, neurology, nephrology, gastroenterology, immunology and others. Oncology segment is the dominant sector which emphasizes the use of different radioisotopes for treating various cancers and overcome the side effects of therapeutics. Brachytherapy is a sub segment of oncology application which signifies the methods of treating cancer through implants, surgery or radiation technology. The segment is expected to have a significant growth during the forecast period.

Geographically, the global radiopharmaceutical market has been categorized into five major regions and the key countries in the respective region: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, Japan, China, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, Saudi Arabia, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Browse Global Strategic Business Report:

http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html

Radiopharmaceutical Market: Competitive Landscape

The report also profiles major players in the global radiopharmaceutical market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Advanced Accelerator Applications (AAA), Eckert & Ziegler, GE Healthcare, IBA Radiopharma Solutions, Lantheus Holdings, Inc., Mallinckrodt plc., Nordion, Inc., Siemens Healthineers, and Positron Corporation.

The global radiopharmaceutical market has been segmented as follows:

Global Radiopharmaceutical Market, by Radioisotope

Technetium-99
Gallium-67
Iodine-123
18F
Rubidium-82
Yttrium-90
Lutetium-177
Global Radiopharmaceutical Market, by Source

Nuclear Reactors
Cyclotrons
Global Radiopharmaceutical Market, by End-user

Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
Global Radiopharmaceutical Market, by Application

Cardiology
Gastroenterology
Oncology
Brachytherapy
Others
Nephrology
Neurology
Immunology
Others
Global Radiopharmaceutical Market, by Region

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiopharmaceutical Market Future Trends And Industry Analysis To 2024 here

News-ID: 469750 • Views: 419

More Releases from Transparency Market Research – Pharmaceutical

Plasma Protease C1-inhibitor Treatment Market Estimated to Flourish by 2025
A fresh market intelligence study by Transparency Market Research (TMR) states that the business landscape of the global plasma protease c1-inhibitor treatment market is consolidated with intense competitive rivalry among leading players. TMR detects Shire plc led the global plasma protease C1-inhibitor treatment market in 2016. Key factors that account for its dominance are expanded product portfolio, acquisitions, and widespread market presence. Pharming Group N.V., CSL Limited, and Sanquin are
Narcolepsy Market - Global Industry Trends and Forecast - 2019
Narcolepsy is a chronic neurological disorder, which is characterized by brain’s inability to control the sleep-wake cycle of an individual. This disorder is not caused due to any mental illness, but is mainly caused due to genetic abnormalities occurring from environmental factors or biologic factors. Narcoleptic individuals exhibita typical characteristic symptom, i.e. excessive daytime sleepiness (EDS), where individuals experience disturbed night sleep and abnormal daytime sleep pattern. Narcolepsy disorder is
Diabetic Macular Edema Market - Key Growth Factors and Forecast 2019
Macular edema is the condition when the fluid and proteins start collecting on or under the macula of the eye thereby resulting in swelling. Due to such swelling, a person’s central eye vision gets distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME). Obtain Report Details @ http://www.transparencymarketresearch.com/diabetic-macular-edema-market.html Diabetic macular edema is the major reason for loss of vision in patients
Primary Systemic Amyloidosis Market- Get Facts About Business Strategies and Fin …
Amyloids are the substance made up of abnormally formed protein in the bone marrow that gets saturated in different tissues or organs of the body. The condition is termed as amyloidosis. There are various types of amyloidosis out of which primary systemic amyloidosis are most common, these are associated with plasma cell dyscrasia and has no historical evidence of disease. Kidney, intestines, liver, heart and nerves are the common organs

All 5 Releases


More Releases for Radiopharma

Global Radiosynthesis Equipment Market by Trends, Dynamic Innovation in Technolo …
The Radiosynthesis Equipment Market report includes overview, which interprets value chain structure, industrial environment, regional analysis, applications, market size, and forecast. The report provides an overall analysis of the market based on types, applications, regions, and for the forecast period from 2020 to 2026. It also offers investment opportunities and probable threats in the market based on an intelligent analysis. This report focuses on the Global Radiosynthesis Equipment Market trends, future
Automated Radiosynthesis Modules Market 2019 | Global Forecast 2025 | Top Key Pl …
As per the latest research study published by Up Market Research, “Global Automated Radiosynthesis Modules Market” is estimated to grow at a healthy CAGR % in the coming years. The research report showcases qualitative and quantitative estimations by the industry analysts. The report documents first-hand data, post verification from the industry experts along with each industry manufacturers by the market valuation. Automated Radiosynthesis Modules Market report also gives an extensive
Global Radiopharmaceutical Market 2019 Advancements – Advanced Accelerator App …
Researchmoz added Most up-to-date research on "Radiopharmaceutical Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2024" to its huge collection of research reports. This report on the radiopharmaceutical market analyzes the current and future scenario of the global market. Increase in incidence of various diseases, development of new sources for radioisotope production, and rise in demand for nuclear medicine are boosting the radiopharmaceutical market. Increase in
Radiopharmaceuticals Market to 2016-2026: Advanced Accelerator Applications (Fra …
Researchmoz added Most up-to-date research on "Radiopharmaceuticals Market: Will Japan (Expected to Register an Attractive Growth Rate Throughout the Forecast Period) Beat Current Market Leader North America? - Global Industry Analysis and Opportunity Assessment, 2016-2026" to its huge collection of research reports. North America is anticipated to be the most attractive regional market in the global radiopharmaceuticals market North America accounted for more than 40% market share in the global radiopharmaceuticals market
Radiopharmaceuticals Market Competitive Scenario of Leading Key Players 2016 and …
Presence of radiopharmaceuticals in cancer medications has increased as research institutes have derived ways in which radioisotopes can impede the maturation of malignant tumour, cells and tissues. Increasing significance of radiotracers in therapeutic care of cancer and cardiovascular diseases has also impacted the growth in demand for radiopharmaceuticals. To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-1992 In a recent report published by Future Market Insights, the global radiopharmaceuticals revenues in 2016 reached
Automated Radiosynthesis Modules Market – Product Diversification 2025 | IBA R …
Global Automated Radiosynthesis Modules Market: Snapshot The global automated radiosynthesis modules market is forecasted to be a million-dollar opportunity for industry participants expected to be encouraged by a colossal demand in the recent years. End users of automated radiosynthesis modules could ensure an improved performance in their therapy monitoring and diagnostic activities. With the help of these modules, end users could also gain a wide scope for the customization of radiotracers.